A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients - Concepedia

Concepedia

Publication | Closed Access

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients

101

Citations

18

References

2010

Year

Michael Siebels, K. Rohrmann, R. Oberneder, Michael S. Stahler, Nicolas Haseke, Joachim Beck, Rainer Hofmann, Manfred Kindler, Pia Kloepfer, Christian G. Stief

World Journal of Urology

UrologyGenitourinary CancerMedicineRenal PathologyImmunologyMonoclonal Antibody Cg250Cancer TreatmentOncologyKidney Research

References

	Year	Citations

Page 1

Page 1